T-cell subsets and suppressor cells in human bone marrow - PubMed (original) (raw)
. 1992 Dec 15;80(12):3242-50.
Affiliations
- PMID: 1467527
Free article
T-cell subsets and suppressor cells in human bone marrow
I G Schmidt-Wolf et al. Blood. 1992.
Free article
Abstract
To characterize immune suppressive and hematopoietic features of enriched subsets of human marrow cells, we separated these cells on Percoll density gradients. CD4+ and CD8+ T cells (CD3+) were enriched in the high-density marrow cell fractions and reduced in low-density fractions. CD4-CD8- (CD3+) T cells expressing the alpha beta T-cell antigen receptor were at least 10 times less numerous than the CD4+ and CD8+ T cells in all fractions. Purified populations of the CD4-CD8- alpha beta + T cells obtained by flow cytometry suppressed the mixed leukocyte reaction (MLR). Another population of suppressor cells that expressed neither T-cell (CD3) nor natural killer cell (CD16) surface markers was also identified. The latter cells had the phenotypic and functional characteristics of "natural suppressor" cells. Suppressor cell activity was enriched in the low-density fractions along with hematopoietic progenitors (colony-forming unit-granulocyte-macrophage and burst-forming unit-erythroid). The progenitor and suppressor cell activities were depleted in high-density fractions. The latter fractions made vigorous responses in the MLR. The low-density fractions, which accounted for less than 10% of the input marrow cells, suppressed the MLR and did not respond. Further evaluation of the low-density fractions may be of value in allogeneic bone marrow transplantation due to the reduction of CD4+ and CD8+ T cells and the enrichment of hematopoietic progenitors as well as immune suppressor cells that may inhibit graft-versus-host disease.
Similar articles
- Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors.
Kusnierz-Glaz CR, Still BJ, Amano M, Zukor JD, Negrin RS, Blume KG, Strober S. Kusnierz-Glaz CR, et al. Blood. 1997 Apr 1;89(7):2586-95. Blood. 1997. PMID: 9116306 - Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Schriber JR, Dejbakhsh-Jones S, Kusnierz-Glaz CR, Ginzton N, Still B, Negrin RS, Greenberg P, Strober S. Schriber JR, et al. Exp Hematol. 1995 Aug;23(9):1024-9. Exp Hematol. 1995. PMID: 7543414 - Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
Palathumpat V, Dejbakhsh-Jones S, Holm B, Strober S. Palathumpat V, et al. J Immunol. 1992 Aug 1;149(3):808-17. J Immunol. 1992. PMID: 1386094 - Influence of graft versus host reaction on the T cell repertoire differentiating from bone marrow precursors following allogeneic bone marrow transplantation.
Onoé K, Arase N, Arase H, Takayanagi T, Nishihori H, Iwabuchi K, Ogasawara K, Good RA. Onoé K, et al. Transpl Immunol. 1997 Jun;5(2):75-82. doi: 10.1016/s0966-3274(97)80046-9. Transpl Immunol. 1997. PMID: 9269028 Review. - Natural killer 1.1(+) T cells and "natural suppressor" T cells in the bone marrow.
Strober S. Strober S. J Allergy Clin Immunol. 2000 Jul;106(1 Pt 2):S113-4. doi: 10.1067/mai.2000.106057. J Allergy Clin Immunol. 2000. PMID: 10887344 Review.
Cited by
- Human CD4-CD8- alpha beta + T-cell receptor T cells recognize different mycobacteria strains in the context of CD1b.
Thomssen H, Ivanyi J, Espitia C, Arya A, Londei M. Thomssen H, et al. Immunology. 1995 May;85(1):33-40. Immunology. 1995. PMID: 7543448 Free PMC article. - Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S. Srivastava MK, et al. PLoS One. 2012;7(7):e40677. doi: 10.1371/journal.pone.0040677. Epub 2012 Jul 16. PLoS One. 2012. PMID: 22815789 Free PMC article. - Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
Shaulov A, Yue S, Wang R, Joyce RM, Balk SP, Kim HT, Avigan DE, Uhl L, Sackstein R, Exley MA. Shaulov A, et al. Exp Hematol. 2008 Apr;36(4):464-72. doi: 10.1016/j.exphem.2007.12.010. Epub 2008 Feb 8. Exp Hematol. 2008. PMID: 18261838 Free PMC article. - Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.
Dilek N, Vuillefroy de Silly R, Blancho G, Vanhove B. Dilek N, et al. Front Immunol. 2012 Jul 17;3:208. doi: 10.3389/fimmu.2012.00208. eCollection 2012. Front Immunol. 2012. PMID: 22822406 Free PMC article. - Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.
Albeituni SH, Ding C, Yan J. Albeituni SH, et al. Cancer J. 2013 Nov-Dec;19(6):490-501. doi: 10.1097/PPO.0000000000000006. Cancer J. 2013. PMID: 24270348 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials